Polynucleotides (PDRN) in Drug Delivery Serum Application Protocols
Polynucleotides (PDRN) plays a key role in professional drug delivery serum application treatments. DNA fragments derived from salmon or trout sperm that activate salvage pathway purine metabolism, stimulating fibroblast proliferation and tissue regeneration.
Role of Polynucleotides (PDRN) in Drug Delivery Serum Application
Enhanced penetration of active ingredients using advanced drug delivery systems including liposomal, nanosomal, and electroporation technology Polynucleotides (PDRN) enhances this treatment through its bio-revitalisation properties, providing regenerative support during and after the procedure.
Protocol Integration
In a typical drug delivery serum application protocol, polynucleotides (pdrn) can be utilised at several stages:
- Pre-treatment: Skin preparation with polynucleotides (pdrn)-containing products to optimise treatment outcomes
- During treatment: Active polynucleotides (pdrn) delivery through the treatment modality for enhanced penetration
- Post-treatment: Recovery support using polynucleotides (pdrn) formulations to accelerate healing
Clinical Benefits
Combining polynucleotides (pdrn) with drug delivery serum application offers several advantages:
- Enhanced bio-revitalisation through professional delivery methods
- Improved treatment outcomes with medical-grade regenerative support
- Reduced downtime and faster recovery when supported by polynucleotides (pdrn)
Skymedic Products
Skymedic offers professional-grade polynucleotides (pdrn) formulations specifically designed for integration with drug delivery serum application protocols. All products manufactured under ISO 13485 standards.